Analysis on the infection among patients with nephrotic syndromes and systemic vasculitis treated with mycophenolate mofetil

Clin Rheumatol. 2010 Sep;29(9):1073-4. doi: 10.1007/s10067-010-1482-7. Epub 2010 May 20.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Nephrotic Syndrome / drug therapy*
  • Opportunistic Infections / epidemiology
  • Respiratory Tract Infections / epidemiology*
  • Risk Factors
  • Systemic Vasculitis / drug therapy*
  • Treatment Outcome
  • Urinary Tract Infections / epidemiology*

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Mycophenolic Acid